Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06534359 · ClinicalTrials.gov registry record · NA
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
A NA study of Gastroesophageal Reflux and Bronchopulmonary Dysplasia, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT06534359: Recruiting NA study of Gastroesophageal Reflux and Bronchopulmonary Dysplasia, sponsored by Children's Hospital of Philadelphia.
NCT06534359 is a NA study of Gastroesophageal Reflux and Bronchopulmonary Dysplasia that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 60 participants, below the 2,884-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06534359, a NA study of Gastroesophageal Reflux and Bronchopulmonary Dysplasia, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The goal of this clinical trial is to learn if transpyloric tube feeding (feeding directly into the small intestine) versus gastric tube feeding tolerably and effectively reduces gastroesophageal reflux in infants born premature who have been diagnosed with bronchopulmonary dysplasia. The main questions this trial aims to answer are: Does transpyloric as compared to gastric tube feeding result in differences in the amount of experienced hypoxemia (low oxygen level in the blood) or serious adverse events? Does transpyloric as compared to gastric tube feeding reduce the frequency and severity of gastroesophageal reflux (GER) measured using 24 hour esophageal pH-multichannel intraluminal impedance (pH-MII) monitoring? Participants will: Undergo pre-trial 24 hour pH-MII monitoring to determine baseline severity of GER. Be randomly assigned to receive transpyloric or gastric tube feeding for 2 weeks. Undergo repeat pH-MII at the end of the 2 week trial to assess for change in GER. Undergo continuous pulse oximetry to record level of hypoxemia during the 2 week trial. Undergo saliva and airway (if supported by a breathing tube) fluid collection to measure biomarkers of GER. Be monitored clinically for possible adverse events.
Primary Outcome
Oxygen saturation will be measured by continuous pulse oximetry throughout the 2 week trial. The proportion of time per day with an oxygen saturation (SpO2) less than 80% will be calculated and reported as a median value observed over the 2 week trial.
Conditions Studied
Interventions
- OTHER Transpyloric tube feeding
- OTHER Gastric tube feeding
Study Locations (3)
California
- Stanford University - Palo Alto
Missouri
- Children's Mercy Hospital - Kansas City
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What NCT06534359 shows while recruiting
NCT06534359 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,884-participant average among 33 other Gastroesophageal Reflux trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Gastroesophageal Reflux appearing as the primary indexed condition, and to 2 interventions - of which Transpyloric tube feeding is the first listed.
NCT06534359 reports a single indexed study location in California, Missouri, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06534359 about?
NCT06534359 is a clinical study titled "Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia". The goal of this clinical trial is to learn if transpyloric tube feeding (feeding directly into the small intestine) versus gastric tube feeding tolerably and effectively reduces gastroesophageal reflux in infants born premature who have been diagnosed with bronchopulmonary dysplasia. The main quest...
What is the current status of trial NCT06534359?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-07-15. Estimated completion is 2027-06-30.
What conditions does trial NCT06534359 study?
This clinical trial studies the following conditions: Gastroesophageal Reflux, Bronchopulmonary Dysplasia.
What interventions are being tested in trial NCT06534359?
The interventions under investigation include: Transpyloric tube feeding (OTHER), Gastric tube feeding (OTHER).
Who is sponsoring clinical trial NCT06534359?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06534359 being conducted?
This trial has 3 study locations across California, Missouri, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastroesophageal Reflux
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06534359's enrollment target sits among peer trials
60 20th of 33 higher than 13 of 33 other Gastroesophageal Reflux trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gastroesophageal Reflux trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
RECRUITING · NA
-
Compassionate Use of Domperidone for Refractory Gastroparesis
RECRUITING · NA
-
External UES Band (Shaker Pressure Band) and GERD
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
-
Establishing Pressures at the EGJ During Diaphragmatic Breathing Using High-resolution Esophageal Manometry
RECRUITING · NA
-
Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI